{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T18:00:46Z","timestamp":1768413646902,"version":"3.49.0"},"reference-count":6,"publisher":"Medknow","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Mycobacteriol"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/ijmy.ijmy_73_18","type":"journal-article","created":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T06:28:13Z","timestamp":1536215293000},"page":"265","source":"Crossref","is-referenced-by-count":12,"title":["Antimycobacterial activity of veterinary antibiotics (Apramycin and Framycetin) against Mycobacterium abscessus: Implication for patients with cystic fibrosis"],"prefix":"10.4103","volume":"7","author":[{"given":"JohnE","family":"Moore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg","family":"Koulianos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoaki","family":"Misawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BCherie","family":"Millar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2581","reference":[{"key":"key-10.4103\/2212-5531.240694-1","first-page":"369","volume-title":"Mycobacterial isolations in young adults with cystic fibrosis","author":"Smith","year":"1984","journal-title":"Thorax"},{"key":"key-10.4103\/2212-5531.240694-2","first-page":"621","volume-title":"Late diagnosis defines a unique population of long-term survivors of cystic fibrosis","author":"Rodman","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.4103\/2212-5531.240694-3","first-page":"390","volume-title":"Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis","author":"Salsgiver","year":"2016","journal-title":"Chest"},{"key":"key-10.4103\/2212-5531.240694-4","first-page":"88","volume-title":"US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: Executive summary","author":"Floto","year":"2016","journal-title":"Thorax"},{"key":"key-10.4103\/2212-5531.240694-5","first-page":"506","volume-title":"Mycobacterium abscessus: Challenges in diagnosis and treatment","author":"Benwill","year":"2014","journal-title":"Curr Opin Infect Dis"},{"key":"key-10.4103\/2212-5531.240694-6","first-page":"6938","volume-title":"In vivo efficacy of apramycin in murine infection models","author":"Meyer","year":"2014","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Mycobacteriology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T12:53:58Z","timestamp":1682081638000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ijmyco.org\/text.asp?2018\/7\/3\/265\/240694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":6,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"alternative-id":["240694"],"URL":"https:\/\/doi.org\/10.4103\/ijmy.ijmy_73_18","relation":{},"ISSN":["2212-5531"],"issn-type":[{"value":"2212-5531","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}